Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Meropenem (1000mg) + Tazobactum (500mg)
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
mono
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Common side effects may include nausea, vomiting, diarrhea, headache, and injection site reactions such as pain or inflammation. Some patients may experience rash or allergic reactions. Rarely, seizures, severe hypersensitivity reactions, or changes in liver enzymes may occur.
Meropenem (1000 mg) + Tazobactam (500 mg) Injection is indicated for the treatment of severe bacterial infections, including complicated intra-abdominal infections, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and septicemia. It is especially effective against resistant organisms by combining a broad-spectrum antibiotic with a beta-lactamase inhibitor.
This injection should be administered under strict medical supervision. Dose adjustment may be required in patients with kidney impairment. Inform your doctor about any history of allergy to beta-lactam antibiotics. Complete the full prescribed course to prevent antibiotic resistance. Avoid unnecessary use to reduce the risk of resistance development.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children. Use immediately after reconstitution as directed.
Composition : Bupivacaine (5mg) Injection
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Benzathine penicillin G (2400000IU) Injection
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefoperazone Sodium (Sterile) I.P. 1000mg + Tazobactam Sodium (Sterile) I.P. 125mg
Composition : Cefoperazone (2gm) + Sulbactam (1gm)
Composition : Colistimethate Sodium (1Million IU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
What are the business opportunities for Merotyle TZ 1.5 Injection in the PCD pharma franchise market?
Medical distributors and agencies can benefit from the high hospital usage of carbapenem combinations used in severe, multi-drug resistant infections such as sepsis, complicated intra-abdominal infections, pneumonia, and ICU-critical cases. Merotyle TZ 1.5 Injection helps strengthen a premium critical care and anti-infective injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Merotyle TZ 1.5 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, good business margins, consistent product supply, professional support, and access to a trusted high-end carbapenem antibiotic combination when partnering for Merotyle TZ 1.5 Injection distribution.
Medical distributors, stockists, and wholesalers interested in Merotyle TZ 1.5 Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.